Study Details
Early Detection of Lung Cancer based on small RNA signatures (Boston II)
(IRB#: IRB_00166058)
This study will see if a new test can diagnose lung cancer. The new test is called the HBDx small RNA diagnostic test for lung cancer. People in this study will participate for 12 months. You will give blood at one clinic visit at the start of the study. This blood will be used to run the new test. We will collect information from your medical record for 12 months after the visit. At the end of 12 months, we will contact you to ask about any imaging, biopsies or surgical procedures you might have had at another healthcare facility.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Adult male and female patients, aged 50 to 80 years
- Had a LDCT (low dose computed tomography scan) in the past 90 days
- Have been referred to undergo further diagnostic procedures for the detection of lung cancer
Exclusion Criteria
- Prior history of diagnosed lung cancer
- History of gastrointestinal, hematological, breast, thyroid, and genitourinary cancer within the past 10 years
- Active infectious diseases
- Taking Immunosuppressive medication
Will I be paid for my time?
Yes
IRB#: IRB_00166058
PI: Chakravarthy Reddy
Department: PULMONARY
Approval Date: 2023-07-27 16:36:00
Study Categories: Lung Cancer Studies
Specialties: Pulmonary